Please ensure Javascript is enabled for purposes of website accessibility

Tag Archives: als

FDA OKs Neuralstem’s ALS clinical trial

Neuralstem Inc., of Rockville, a biotherapeutic company developing products to treat central nervous system disorders with patented stem cell technology, said it received approval from the Food and Drug Administration to begin a Phase II trial using spinal cord-derived human neural stem cells to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

Read More »

Kirkley joins Brigance Brigade

Christine Kirkley has joined The Brigance Brigade as executive director. Kirkley will oversee the activities of the organization and is also responsible for working with Mr. and Mrs. Brigance as well as the Board of Directors to determine the long ...

Read More »